Global Erectile Dysfunction Treatment Market, By Type (Low-Flow or Ischemic Priapism and High-Flow or Non-Ischemic Priapism), Treatment (Medications, Surgery, Psychological Counselling, Penis Pumps, Penile Implants, Others), Drugs (Sildenafil, Tadalafil, Vardenafil, Avanafil and Others, Route of Administration (Oral, Intravenous and Others), Distribution Channel (Direct, Online Pharmacy, Retailers and Others), End Users (Hospitals, Homecare, Specialty Clinics and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of the Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Erectile Dysfunction Treatment Market
The erectile dysfunction treatment market is expected to witness market growth at a rate of 7.6% in the forecast period of 2022 to 2029. Data Bridge Market Research report on the erectile dysfunction treatment market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the patient awareness is escalating the growth of the erectile dysfunction treatment market.
Erectile dysfunction (ED) is referred to as a common sexual problem amongst male population, in which they are incapable to maintain erection during copulation. The hinder is majorly age related and can be caused because of kidney disease, diabetes, high blood pressure, prostate cancer, physical injury to the prostate, penis, and pelvis.
Major factors that are expected to boost the growth of the erectile dysfunction treatment market in the forecast period are the constant clinical trial conducted by many pharmaceuticals companies and the rise in the geriatric population around the world. Furthermore, the inactive lifestyle is further anticipated to propel the growth of the erectile dysfunction treatment market. Moreover, the growing habit of alcoholism and smoking is further estimated to cushion the growth of the erectile dysfunction treatment market. On the hand, the patent expiry of some major drugs is further projected to impede the growth of the erectile dysfunction treatment market in the timeline period.
In addition, the increasing number of campaigns by government and non-government organizations around the globe will further provide potential opportunities for the growth of the erectile dysfunction treatment market in the coming years. However, the decrease in the insurance coverage for erectile dysfunction treatment might further challenge the growth of the erectile dysfunction treatment market in the near future.
The erectile dysfunction treatment market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the erectile dysfunction treatment market scenario, contact Data bridge market research for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.
Global Erectile Dysfunction Treatment Market Scope and Market Size
The erectile dysfunction treatment market is segmented on the basis of types, treatment, drugs, route of administration, distribution channel and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of types, the erectile dysfunction treatment market is segmented into low-flow or ischemic priapism and high-flow or non-ischemic priapism.
- On the basis of treatment, the erectile dysfunction treatment market is segmented into medications, surgery, psychological counselling, penis pumps, penile implants and others.
- On the basis of drugs, the erectile dysfunction treatment market is segmented into sildenafil, tadalafil, vardenafil, avanafil and others.
- On the basis of route of administration, the erectile dysfunction treatment market is segmented into oral, intravenous and others.
- On the basis of distribution channel, the erectile dysfunction treatment market is segmented as direct, online pharmacy, retailers and others.
- On the basis of end user, the erectile dysfunction treatment market is segmented into hospitals, homecare, specialty clinics and others.
Erectile Dysfunction Treatment Market Country Level Analysis
The erectile dysfunction treatment market is segmented on the basis of types, treatment, drugs, route of administration, distribution channel and end user.
The countries covered in the erectile dysfunction treatment market report are the U.S., Canada, and Mexico in North America, Peru, Brazil, Argentina, and the rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).
North America dominates the erectile dysfunction treatment market due to the established healthcare infrastructure. Furthermore, the growing need for erectile dysfunction drugs and the increase in the research and development initiatives regarding the development of novel drug molecules will further boost the growth of the erectile dysfunction treatment market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the erectile dysfunction treatment market due to the rise in the occurrence of erectile dysfunction which leads to infections. Moreover, the increase in the aging population, thriving generic drugs industry, and social stigma is further anticipated to propel the growth of the erectile dysfunction treatment market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The erectile dysfunction treatment market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to the market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Erectile Dysfunction Treatment Market Share Analysis
The erectile dysfunction treatment market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the erectile dysfunction treatment market.
Some of the major players operating in the erectile dysfunction treatment market are Pfizer Inc, Bayer AG, Eli Lilly and Company, APRICUS BIOSCIENCES, INC, Mylan N.V, VIVUS Inc, DONG-A SOCIO HOLDINGS., Amgen Inc, GlaxoSmithKline plc, Tissue Genesis, Sanofi, PHARMICELL Co., Ltd, SK chemicals, Rexahn Pharmaceuticals, Inc., ALLERGAN, and JW Holdings among others.
SKU-